[DealStreetAsia Interview] Hummingbird speaks to DealStreetAsia about the company’s overall drug development this year and its positive outlook on future investments.
17 February, 2021
Hummingbird speaks to DealStreetAsia about Hummingbird’s overall drug development moving into clinical trials this year and why setting milestones drive future investments.
